Midazolam and Euthanasia
notes on the work of Wilson Sy
by Craig Paardekooper

KEY POINTSINVOLUNTARY
1. End of life drugs were prescribed immediately with the beginning of lockdown
2. These drugs were administered by injection in hospitals / care-homes to a captive population – elderly and sick.
DRUG-DEATH CORRELATION
3. There is a consistent 1 month lag between peaks of Midazolam medication and peaks of excess death.
4. The size of the peaks of medication are directly proportional to the size of the peaks of excess death.
5. There is a 1 : 1 correspondence between the number of Midazolam injections and the number of excess deaths
6. In 2020, the correlation between Midazolam medication and excess death is 99%.
MECHANISM
7. Midazolam and Morphine have the highest incidence for depressing respiration.
8. The dosages given match the Guideline and those required for effective euthanasia
POLICY
9. The NICE Guideline states that the intended use of Midazolam and Morphine was end-of-life care.
10. Do Not Resuscitate orders were applied
11. Effective treatments were withheld and discouraged
12. Liability was removed.

CONTENTS

Lock-Step
Prescriptions of Midazolam
Lockdown
In Lock-Step with Lockdown
Drug-Death Correlation
Correlation with Excess Death in UK
Correlation in Each NHS Region
Wales, Scotland and Northern Ireland
PolicyGuidelines
Dosages Given
Hancock Interview
Assisted Dying
Drugs for Assisted Dying
Midazolam and Morphine Effects
Other Medicines Used
Withdrawal of Care
Withdrawal of CareDo Not Resuscitate
No more Liability
Amnesty Report
Conclusion
Anti-Retro-Viral Drugs
Paxlovid
TamifluPRESCRIPTIONS OF MIDAZOLAM contents
Midazolam prescriptions increased during the COVID-19 pandemic. Data from the English Prescribing Dataset,shows a jump in prescriptions of midazolam for “sedative or analgesic” purposes in April 2020. Ref :Openprescribing.net

Here are the values for NHS in London –Here are the values for NHS in the Midlands

Here are the values for NHS in the North West Region UK

Here are the values for NHS in the North East Region UK

Here are the values for NHS in the South West Region UK

Here are the values for NHS in the South East Region UK

Here are the values for NHS in the Eastern Region UK

WHEN DID THE LOCKDOWNS BEGIN ? contents

Lockdown began on March 3rd 2020 and were complete in almost all countries by March 31st 2020.

https://en.wikipedia.org/wiki/COVID-19_lockdowns

It seems anomalous that Midazolam would be prescribed so heavily immediately following the beginning oflockdown.

IN LOCKSTEP WITH LOCKDOWN contents

1. IMMEDIATE : Lockdowns began globally on March 3rd 2020 and were completed by March 31st 2020 for
almost all countries. A huge spike in excess prescriptions for Midazolam began in April 2020, the month
IMMEDIATELY following, but then resumed a more gentle increase. This suggests that the policy ofprescribing Midazolam was part and parcel of the policy of lockdowns. With the start of lockdown large
numbers of people were immediately administered Midazolam.
Mass administration would only be possible if the recipients were under the care and control of the
drug administrator. This would suggest a sick or elderly population – in hospitals or care homes.
The association with lockdown (loss of freedom of movement) suggests that the recipients wereadministered this drug whilst in a state of captivity, isolation- which suggests that the administration
was involuntary – perhaps as a condition of their freedom.
Mass administration also suggests that it was done regardless of personal state of health – by a one
size fits all policy.
2. NATIONAL : Midazolam was used simultaneously in all 7 NHS regions. This suggests that individual
NHS regions or health workers within those regions were not left to decide for themselves upon the useof Midazolam, but rather this decision was made centrally (by government).
The sudden national use of midazolam is anomalous because there were few cases of Covid at thistime, and also because viruses would not spread instantaneously and uniformly to all regions of the UK
in this manner. And finally because in March 2020 Covid had been declared to be a low fatality virus, so
it is anomalous that so many would suddenly need end of life care.
3. NOT OUTSIDE ENGLAND : The April 2020 Midazolam peak only occurred in England. It was absent in
Scotland, Wales and Northern Ireland.
Once again, this is anomalous. If a virus spread so fast and uniformly that it required the mass use of
end of life medications in all 7 NHS regions simultaneously, then we would have expected it to crossborders into Wales, Scotland and Northern Ireland such that they too would need to prescribe end oflife medications.
4. GRADUAL INCREASE THEREAFTER : Besides the massive peaks of usage in April 2020 and January
2021, all graphs show a gradual escalation of usage over the 3 year period of the “pandemic”

The openprescription.net downloaded data also provides the prescription costs. Prescription cost analysis
of monthly administrative data for April 2020 also shows a similar level of prescribing.

CORRELATION BETWEEN MIDAZOLAM USE AND EXCESS DEATHS contents

1.

There is a consistent 1 month lag between peaks of Midazolam medication and peaks of excess death.

2.

The size of the peaks of medication are directly proportional to the size of the peaks of excess death.

3.

There is an approximate 1 : 1 correspondence between the number of Midazolam injections and thenumber of excess deaths.
This degree of correlation is extraordinary !

Source : Excess Deaths in the
United Kingdom: Midazolam andEuthanasia in the COVID-19
Clearly, Midazolam injections
and excess deaths in England
are highly correlated, but notsynchronously, because
medication generally does nothave instantaneous impact andalso reporting of dosages used
and registration of deaths maylag. Shifting the time series forMidazolam injections one-monthforward, very high correlation isseen.

The very high correlation(coefficient 91 percent) between
excess deaths lagged one monthafter Midazolam injections islargely due to the first twoenormous spikes to early 2021.
From April 2021 onwards to May
2023, the same correlation
dropped to 59 percent, but still
statistically significant with pvalue at 0.0007.

MIDAZOLAM USE AND EXCESS DEATHS FOR EACH NHS REGION OF THE UK

contents

Source : Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19
Graphs show that correlation between excess deaths and Midazolam improves substantially when Midazolam
injections lead excess deaths by 1 month. This high correlation is consistent for all NHS regions of England.
The correlation is greatest in 2020 prior to vaccination, when it reached 99%. The lower correlation after
vaccination rollout may be due to the contributing factor of vaccination to fatal outcomes.

Source : Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19

NO EXCESS DEATHS IN WALES, SCOTLAND AND NORTHERN IRELAND contents

The two peaks of excess death, occurring in 2020 in England and in early 2021 in England, are completely
missing from the data for Wales, Scotland and Northern Ireland.
The peak of excess deaths in England in 2020 is seen in the data for all 7 NHS regions, but is absent in the data
for Scotland, Wales and Ireland. If this peak was caused by a virus spreading rapidly throughout the 7 regions
of England then we would not expect it to stop at national boundaries.
Policy however does stop at national boundaries, so we should see if England had a unique policy of treating
Covid patients with end-of-life medications such as Midazolam which the other countries did not have.

Source : Dr Chris Martenson, toxicologist, - Dr Chris Martenson - video : (see @ 37 min 52 secs)

NICE GUIDELINES contents

The simultaneous administration of Midazolam in April 2020 in all 7 NHS regions suggests a national policy was
implemented immediately after the start of lockdowns.
We find this policy in the new guidelines published on April 3rd 2020 by the National Institute for Health andCare Excellence (NICE) for managing COVID-19 symptoms, including those at the end-of-life.

NICE has taken down the original guideline, but it can befound on the wayback machine here – Way Back Link
It is also available here – How Bad Link

The NICE rapid guidelines on treatments in the last days and last hours of life for managing breathlessness for
adult patients are found in Table 5 – shown below

Conditions for use
1. Person at end of life
2. Moderate breathlessness
3. Person distressed

Note : Their method of managing
breathlessness is to induce MORE
breathlessness, since bothMidazolam and Morphine depress
respiration.

Note : They advise “Sedation andopioid use should not be withheld
because of fear of causing
respiratory depression.”

WHAT DOSAGES OF MIDAZOLAM AND MORPHINE SULPHATE WERE GIVEN IN APRIL 2020? contents

Using https://openprescribing.net we can see which dosages of Midazolam have a peak in April 2020 –

•
•
•
•
•
•

Drug dosage and concentration of Midazolam
10mg in 2ml of solution
10mg in 5ml of solution
2mg in 2ml of solution
50mg in 10ml of solution
5mg in 2ml of solution
5mg in 5ml of solution

Max Doses per region
6918
87
75
2
1
250

The dosage of Midazolam used most in April 2020 was 10mg in 2ml of solution for injection ampoules. This isprecisely the dosage outlined in the NICE Guideline to be used for euthanasia and end-of-life care.

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Drug dosage and concentration of Morphine Sulphate

Max Doses per region

5mg in 5ml of solution
60mg in 2ml of solution
5mg in 1ml of solution
5mg in 10ml of solution
50mgin 5ml of solution
4mg in 10ml of solution
30mg in 1 ml of solution
300mg in 10ml of solution
2mg in 5ml of solution
2mg in 10ml of solution
2.5mg in 5ml of solution
20mg in 2ml of solution
20mg in 1ml of solution
1mg in 1ml of solution
15mg in 1ml of solution
10mg in 2ml of solution
10mg in 1ml of solution

25
23
0
0
1
0
133
0
0
0
0
0
79
6
49
1
5710

The dosage of Morphine sulphate used most in April 2020 was 10mg in 1ml of solution for injection ampoules.
The second most frequently used was 30mg in 1ml of solution. This is precisely the dosage outlined in the NICE
Guideline to be used for euthanasia and end-of-life care.
At these dosages, Midazolam and Morphine Sulphate have the dual effect of pacifying the recipient whilst
hastening death – especially in those suffering from acute respiratory infection who are breathless to begin
with. Both Opioids and Midazolam depress respiration further.
Breathlessness is a common symptom of a respiratory infection. Their method of managing breathlessness forpatients 18 years old and older is to induce MORE breathlessness, since both Midazolam and Morphine
depress respiration.

WHAT ARE THE DRUGS AND DOSAGES FOR ASSISTED DYING ? contents

These can be found here - Efficacy and Safety of Drugs Used for Assisted Dying

For Assisted Dying :••A dosage of 10mg of Midazolam
A dosage of 15mg to 3g of Morphine

For Euthanasia :••A dosage of 2mg to 120mg of Midazolam
A dosage of 16mg to 480mg of Morphine

Sedatives

Chloral Hydrate

20 g

Amitriptyline

Not reported

Sedatives

Barbiturates

Propofol

1000–2000 mg

Vesparax

Not reported

Chloral Hydrate

35–40 mg

Benzodiazepines

Pentobarbital

9–15 gDiazepam

10–120 mg

Phenobarbital

20 g

Lorazepam

1.5–5 mg

Secobarbital

9–15 gMidazolam

2–120 mg

Brallobarbital

Not reported

Barbiturates

Sodium Thiopental

Not reported

Benzodiazepines
Diazepam

1g

Lorazepam

0.25–2 mg

Midazolam

10 mg

Analgesics Opioids
Morphine

15 mg-3 g

Detropropoxyphene

Not reported

Cardiotoxic Digoxin
Propranolol
Antiemetic
Metoclopramides
Ondansetron

Analgesics

Pentobarbital

1–15 gThiopental

1–2 g

Secobarbital

9g

Phenobarbital

3000 mg

Opioids
Morphine

16–480 mg

Fentanyl25–1500 μg

Neuromuscular
Mivacurium
blockers

50 mg
2g
Cardiotoxic

Not reported50–
100 mg45 g

Pancuronium

18–20 mg

Rocuronium

50–300 mg

Cisatracurium

30–40 mg

Vecuronium

10–60 mg

CurareNot reported

Potassiumchloride

Not reported

Bupivacaine

400 mgHaloperidol

See also https://www.jpsmjournal.com/article/S0885-3924(18)30339-7/fulltext

EFFECT OF MIDAZOLAM AND MORPHINE ON RESPIRATORY DEPRESSION contents

Data source :Eudra-vigilance data for all medicines, substances, products and vaccines between 2017 and 2024. [500 Mb
compressed].
Note : The single-line datafile is case-sensitive. Each symptom should be converted to lower case.

Download link https://www.dropbox.com/scl/fi/phs3y74e3fytltuuv7otx/eudra.zip?rlkey=5hwm09juhwp7cmks6qx8uw17a&st=
lhie7ev0&dl=0

Method 1
1.
2.
3.
4.
5.
6.

The multi-line data file was used.
All records where the REACTION is null were removed.
All records where the DRUG is null were removed.
All report records for Midazolam where selected from the Eudra-vigilance data.
The frequency of each unique symptom in the filtered records was counted.
Each symptom count was divided by the total number of symptoms (10698) to give the percentage of all
symptoms for Midazolam.

Results
Table 1 : Incidence of each symptom for Midazolam
REACTION
Empty
Anaphylactic shock
Anaphylactic reaction
Drug ineffective
Respiratory depression
Anaesthetic complication neurologicalHypotension
Respiratory arrest
Death
SeizureHypotension ,Off label use
Cardiac arrest
Anaphylactoid reaction
ApnoeaOxygen saturation decreased
Urticaria
Withdrawal syndrome
Overdose
Delirium
Off label use ,Respiratory depression
Rash
Delayed recovery from anaesthesia
Depressed level of consciousness
Sedation complication

FREQ
522
337
282
193
168
151
114
100
88
83
78
69
64
57
55
54
52
50
49
48
48
46
44
41

%
4.88
3.15
2.64
1.80
1.57
1.41
1.07
0.93
0.82
0.78
0.73
0.64
0.60
0.53
0.51
0.50
0.49
0.47
0.46
0.45
0.45
0.43
0.41
0.38

It can be seen that almost all of the most common symptoms have to do with respiratory arrest or respiratory
depression – meaning less oxygen is carried by the blood, and consciousness is depressed. One of thesymptoms – apnoea – is where the breathing reflex stops during sleep !.
So we can see that the most dominant symptoms of Midazolam is depression of respiration.

But how does this level of respiratory depression compare with all the other 25,000 drugs in Eudra-vigilance? Toanswer this I took one symptom – “respiratory depression” – and counted the frequency of this symptom in allother drugs.
Midazolam had the highest rank out of all of these drugs. Morphine is a very close third.

Table 2 : Incidence of “Respiratory Depression” for all drugs in Eudra-vigilance
DRUG[MIDAZOLAM HYDROCHLORIDE][PIRITRAMIDE][MORPHINE][REMIFENTANIL HYDROCHLORIDE][REMIFENTANIL, REMIFENTANIL HYDROCHLORIDE][MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM MALEATE]RISPERIDONE [RISPERIDONE]NALOXONE [NALOXONE, NALOXONE HYDROCHLORIDE, NALOXONEHYDROCHLORIDE DIHYDRATE][REMIFENTANIL][FENTANYL][MORPHINE HYDROCHLORIDE][MORPHINE, MORPHINE HYDROCHLORIDE][PETHIDINE, PETHIDINE HYDROCHLORIDE][PETHIDINE HYDROCHLORIDE]GLUCAGON [GLUCAGON, GLUCAGON HYDROCHLORIDE][MORPHINE SULFATE, MORPHINE SULFATE PENTAHYDRATE]DEXMEDETOMIDINE [DEXMEDETOMIDINE][VECURONIUM BROMIDE][BENZATROPINE][DIHYDROCODEINE, DIHYDROCODEINE TARTRATE BP][BUPRENORPHINE HYDROCHLORIDE][FLUNITRAZEPAM]FENTANYL CITRATE [FENTANYL CITRATE][METHADONE HYDROCHLORIDE]

FREQ
68
31
19
14
38
104
91

TOT
483
222
145
157
494
1398
1297

%
14.08
13.96
13.10
8.92
7.69
7.44
7.02

18
28
72
44
142
10
20
20
41
27
13
19
10
38
11
92
35

261
436
1156
895
3192
231
470
504
1036
715
349
524
286
1125
341
2894
1113

6.90
6.42
6.23
4.92
4.45
4.33
4.26
3.97
3.96
3.78
3.72
3.63
3.50
3.38
3.23
3.18
3.14

Summary
1.

When we look at Midazolam on its own, the most frequent symptoms are all to do with respiratory
depression

2.

When we compare Midazolam with all other drugs for the symptom of respiratory depression, we findthat Midazolam occupies the highest rank – it has the greatest incidence of all drugs for this symptom..

OTHER MEDICINES USED FOR END OF LIFE IN APRIL 2020 ? contents

Medicines that can increase the risk of respiratory depression include benzodiazepines such as midazolam ordiazepam, particularly when used in combination with other psychotropic medicines such as antidepressants,
antipsychotics, anticonvulsants or sedatives such as phenobarbital.

BENZODIAZEPINESFENTANYL
From April 2022 onwards there is a higher use of Fentanyl. Fentanyl is as powerful as Morphine for depressing respiration.
This was used particularly in the Midlands NHS region.

POTASSIUM CHLORIDE
In the context of euthanasia, potassium chloride is used to stop the heart. Shows peaks every July during the“pandemic”. This was used particularly in the Midlands NHS region.

FURTHER RESEARCH
To get a full picture of changes in drug use in April 2020 and over the “pandemic” period, it will be necessary to
download the openprescribing database in full, determine the frequency of all prescribed drugs in each month.
Eudra-vigilance data has the reports of adverse events for every drug by date. For any one drug this frequency
will be proportional to the number of doses prescribed, so we can determine an increase in doses prescribed if
number of reports increases.

HANCOCK INTERVIEW contents

The immediate implementation of this policy in April 2020 indicates that supplies had to be in place
beforehand – supplies of –•••Midazolam and Morphine Sulphate solution ,Syringes
Trained personnel willing to administer end of life medications

Obtaining supplies and organising training would have required months of preparation and pre-planning.
The focus of the dialog between Dr Evans and Mat Hancock was not on discussing or suggesting cures, butrather on assuming that death would be inevitable for many, and should therefore be assisted.
The interview feels like theatre, to create the impression that Mr Hancock was only doing what was necessary that there was nothing odd in preparing for mass assisted dying.
Given what we now know about the low rate of death from COVID amongst unvaccinated populations, it does
seem odd that they were purchasing all these end-of-life drugs in advance.
Interview Link

WITHDRAWAL OF STANDARDS OF CARE contents

There is a general feeling that during the pandemic doctors and nurses abandoned their hypocritic oath byadministering vaccines that caused significant observable harm. Well, many never took this oath to begin with.
And such an abandonment of the duty and standards of care is also evident in 2020, prior to the vaccination
rollout –MEDICATION
1. Suspension of medicines that work – ivermectin, HCQ, vitamin D, antibiotics, steroids.
2. Use of medicines that hasten death – Remdesivir, Paxlovid, Tamiflu, Midazolam
TREATMENT
3. Suspension of vital treatments and check-ups.
4. Do not resuscitate orders
5. Use of very harmful treatments such as ventilators.
DIAGNOSIS6. False diagnosis of infection. See
7. False attribution of death to Covid
8. False attribution of infection to healthy asymptomatic

Metaphorically, care-workers took off their white coats, relieved of their tiresome duty, and began to dance. It
was as if the End had come, and concern for health no longer mattered.
Perhaps the clearest example of “withdrawal of care” is the imposition of “Do Not Resuscitate” orders

DO NOT RESUSCITATE contents

The use of blanket DNAR notices in hospitals and care homes was a systemic policy of euthanasia, when it was
not investigated or stopped by government regulators. See DNRJOINT INVESTIGATION
From a joint investigation by the House of Commons and House of Lords, the UK Parliament admitted [36] inSeptember 2020:“Blanket use of Do Not Attempt Cardiopulmonary Resuscitation (DNACPR) notices in care homes
constitutes a systematic violation of individuals’ rights. The Government must ensure that their blanket
use is not allowed.”
Again, the UK government’s response to COVID-19 was a systematic violation of human rights – the right to life,
not euthanasia which is a criminal offence. Many cases were nonvoluntary euthanasia, which were different
from voluntary assisted dying. The UK Parliament reported [36]:“We have received deeply troubling evidence from numerous sources that during the Covid-19
pandemic DNACPR notices have been applied in a blanket fashion to some categories of person bysome care providers, without any involvement of the individuals or their families.”“The blanket imposition of DNACPR notices without proper patient involvement is unlawful. The
evidence suggests that the use of them in the context of the Covid-19 pandemic has been widespread.”

CARE QUALITY COMMISSION
The Care Quality Commission (CQC), which is an independent regulator funded from fees of hospitals and carehomes to oversight them, was asked belatedly to review DNACPR decisions during the COVID-19 pandemic:“It was prompted by concerns about the blanket application of DNACPR decisions, that is applying
them to groups of people rather than on an assessment of each person’s individual circumstances, andabout making decisions without involving the person concerned.”
Emphasis added. In its interim report released in November 2020, the CQC agreed with UK government
investigation and observed somewhat apologetically [37]:“It is clear that there was confusion and miscommunication about the application of DNACPRs at thestart of the pandemic, and a sense of providers being overwhelmed. There is evidence of unacceptable
and inappropriate DNACPRs being made at the start of the pandemic.”

AMNESTY INTERNATIONAL contents

Amnesty International UK published [35] a 2020 report titled: “As if expendable: The UK government’s failure toprotect older people in care homes during the COVID-19 pandemic” which stated:“The UK government, national agencies, and local-level bodies have taken decisions and adopted
policies during the COVID-19 pandemic that have directly violated the human rights of older residents
of care homes in England—notably their right to life, their right to health, and their right to nondiscrimination. These decisions and policies have also impacted the rights of care home residents to
private and family life, and may have violated their right not to be subjected to inhuman or degrading
treatment.”

WITHDRAWAL OF LIABILITY FOR MALPRACTICE contents

In August of 2020 the UK Government held an “open consultation” on changes to Human Medicine
Regulations. The proposed changes were to exempt Pharma of any liability – removing any safe-guard against
malpractice, any safeguard against the distribution of dangerous drugs.
I created a leaflet that was posted through doors in my neighbourhood and placed in shop windows –CONCLUSION contents

In his paper - Excess Deaths in the United Kingdom: Midazolam and Euthanasia in the COVID-19 - Dr Wilson St
concludes “The COVID-19 pandemic in UK was iatrogenic (drug induced), as it did not originate from the SARSCoV-2 virus, but originated from Midazolam use in euthanasia and then likely later from massvaccination. The main findings supporting this conclusion are:•

There were relatively few cases of infections in early 2020, indicating the non-prevalence of the
SARS-CoV-2 virus in the UK.

•

The UK Health Security Agency declared on 19 March 2020, the absence of any “high consequence
infectious disease”, denying the existence of a pandemic.

•

The enormous spike in excess deaths attributed to COVID-19 was inconsistent with the lack ofprevalence of the SARS-CoV-2 virus, which was not verified, due to shortages and unreliability of
PCR tests.

•

NHS and Nightingale hospitals were mostly empty, confirming absence of a pandemic.

•

The excess deaths were spread uniformly and simultaneously across all English regions,inconsistent with natural contagion.

•

The spikes in excess deaths across all regions were strongly correlated with Midazolam injections,
implicating euthanasia, particularly of the elderly in care homes.

•

On investigation, the UK Government, Amnesty International and the Care Quality Commission
have all acknowledged that “a systemic or structural dysfunction in hospital services” and thewidespread blanket use of “Do Not Attempt Cardiopulmonary Resuscitation” (DNACPR) notices incare homes have contributed to excess deaths in the UK”

If the elderly and sick were targeted in this way, then what happened in the UK should serve as a warning tocommunities throughout the world.
There is a malign intention towards the elderly that regards them as expendable – as unproductive and uselesseaters – despite their years of service – and seeks to eliminate them prematurely. This threat is very real. Protect
and care for your elderly and sick. Don’t abandon them to institutional care.
There is a wolf is at the door.

PAXLOVID and TAMIFLU contents

Remdesivir was the anti-viral used in USA and Europe. The toxicity of Remdesivir is shown here –https://howbad.info/rem2.pdf. Remdesivir belongs to a family of drugs called “anti-retro-viral” drugs that cause
kidney and liver injury. This family of drugs includes Paxlovid (Ritonavir), and Tamiflu.
There are no records of prescriptions of either Remdesivir or Veklury in the openprescribing.net database.
However Eudra-vigilance shows many records of adverse events for this drug in Europe from May 2020
onwards. The use of Remdesivir as an anti-viral in 2020 will have induced much toxicity through impairing liverand kidney functions.
After the Covid Pandemic ended in the UK in May 2023, Paxlovid began to be prescribed in England, and shows
up in the openprescribing database from July 2023 onwards. In this post-pandemic phase, Paxlovid will haveinduced much toxicity through impairing liver and kidney function. See – Link

In December 2022, the MHRA approved the Covid vaccine for children aged 6 months to 4 years. Tamiflu wasintroduced in the UK during the flu season in the winter of 2022 and again in the winter of 2023, and targeted atchildren 1 year and older. See – Link
Prior to that it had been prescribed in the winter of 2019 and January 2020. The subsequent ill health ofchildren,due to liver and kidney toxicity, may have served as a motivating factor at the start of the “pandemic”.

Appendix : Python Code for Reading the Data contents

1. Getting frequency of each symptom of Midazolam

2. Comparing Midazolam with all other drugs for frequency of the symptom “respiratory depression”